Advisor Group Holdings, Inc. Harmony Biosciences Holdings, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,188 shares of HRMY stock, worth $40,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,188

Previous 1,169 1.63%

Holding current value

$40,427

Previous $36,000 11.11%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$26.76 - $38.05 $508 - $722	19 Added 1.63%	1,188 $32,000
Q2 2025 Sep 04, 2025	BUY	$27.94 - $35.91 $9,387 - $12,065	336 Added 40.34%	1,169 $36,000
Q2 2025 Aug 13, 2025	SELL	$27.94 - $35.91 $7,180 - $9,228	-257 Reduced 23.58%	833 $26,000
Q1 2025 May 12, 2025	BUY	$32.18 - $40.46 $5,760 - $7,242	179 Added 19.65%	1,090 $36,000
Q4 2024 Jun 06, 2025	SELL	$31.86 - $41.49 $4,269 - $5,559	-134 Reduced 12.29%	956 $32,000

Q4 2024 Feb 07, 2025	BUY	$31.86 - $41.49 $127 - $165	4 Added 0.44%	911 $31,000
Q3 2024 Nov 13, 2024	BUY	$30.0 - $39.95 $20,160 - $26,846	672 Added 285.96%	907 $36,000
Q2 2024 Aug 13, 2024	BUY	$28.81 - $33.01 $6,770 - $7,757	235 New	235 $7,000
Q4 2023 Feb 12, 2024	SELL	$19.2 - $33.78 $51,513 - $90,631	-2,683 Reduced 84.5%	492 $15,000
Q3 2023 Nov 13, 2023	BUY	$31.89 - $39.03 $46,304 - $56,671	1,452 Added 84.27%	3,175 $104,000
Q2 2023 Aug 10, 2023	SELL	$30.5 - $37.4 $18,940 - $23,225	-621 Reduced 26.49%	1,723 $60,000
Q1 2023 May 12, 2023	SELL	$30.8 - $53.92 $279,386 - $489,108	-9,071 Reduced 79.47%	2,344 $76,000
Q4 2022 Feb 10, 2023	BUY	$45.4 - $60.91 $293,193 - $393,356	6,458 Added 130.28%	11,415 $628,000
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $552,584 - $728,502	-13,138 Reduced 72.61%	4,957 $219,000
Q2 2022 Aug 10, 2022	SELL	$33.54 - $52.15 $52,557 - $81,719	-1,567 Reduced 7.97%	18,095 $882,000
Q1 2022 May 04, 2022	BUY	$33.14 - $51.13 $647,091 - $998,364	19,526 Added 14357.35%	19,662 $957,000
Q3 2021 Nov 05, 2021	BUY	$25.68 - $38.61 $3,492 - $5,250	136 New	136 $5,000
Q1 2021 May 13, 2021	SELL	$27.56 - $40.37 $6,890 - $10,092	-250 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$30.96 - $44.39 $7,740 - $11,097	250 New	250 $8,000

Others Institutions Holding HRMY

# of Institutions

317

Shares Held

43.8M

Call Options Held

1.05M

Put Options Held

310K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.01B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Harmony Biosciences Holdings, Inc. Transaction History